Johnson & Johnson (JNJ)

133.24
0.93 0.69
NYSE : Health Care
Prev Close 134.17
Open 134.16
Day Low/High 133.18 / 134.74
52 Wk Low/High 109.32 / 137.08
Volume 1.16M
Avg Volume 5.58M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 357.99B
EPS 6.00
P/E Ratio 22.42
Div & Yield 3.36 (2.50%)

Latest News

Stocks Rise as CEOs Find They Can Denounce Trump and Survive

Stocks Rise as CEOs Find They Can Denounce Trump and Survive

Wednesday was not a good day for President Donald Trump. It wasn't half-bad for markets.

Cramer: Investors Can't Get Enough of Bristol-Myers Despite Latest Drug Setback

Cramer: Investors Can't Get Enough of Bristol-Myers Despite Latest Drug Setback

Despite a Phase 3 stumble, BMY stock is holding up.

Cramer: How Picking Stocks Is Like Fantasy Football

Cramer: How Picking Stocks Is Like Fantasy Football

Hear me out: The same lessons and disciplines are useful in both.

Don't Get Out of Joint

Don't Get Out of Joint

Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.

CEOs Dump Donald Trump

CEOs Dump Donald Trump

CEOs exit President's Council after Charlottesville response

Intel Chief Joins CEOs of Merck, Under Armour in Exiting Trump Business Council

Intel Chief Joins CEOs of Merck, Under Armour in Exiting Trump Business Council

CEO advisors to President Donald Trump largely remained on the sidelines in the wake of racist violence in Charlottesville, Va. over the weekend.

EY's Kerrie MacPherson:

EY's Kerrie MacPherson: "If You Can See It, You Can Be It"

EY's Kerrie MacPherson wants to remove the barriers for young women.

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

EY's Kerrie MacPherson Wants To Pave the Way for future female entrepreneurs.

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

The companies are subject to either state, federal or congressional inquiries into their marketing practices for prescription opioids, which are blamed for helping to fuel rising numbers or addicted individuals.

Achillion Pharmaceuticals Stock Falls, Baird Downgrades Over Lack of Confidence

Achillion Pharmaceuticals Stock Falls, Baird Downgrades Over Lack of Confidence

Thursday's downgrade is in part based on a lack of confidence in Achillion's CH-4471 to compete with Alexion Pharmaceuticals' Soliris treatment.

Chart Signals End to Dollar Trend

Chart Signals End to Dollar Trend

The dollar index is now in an area of strong support.

How To Know A Stock Is Right For You: Cramer's 'Mad Money' Recap (Friday, 8/4/17)

How To Know A Stock Is Right For You: Cramer's 'Mad Money' Recap (Friday, 8/4/17)

Jim Cramer says it's extremely important to buy stocks that are exactly right for you and your level of risk tolerance.

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Geron and Endo and were among the biotech stock movers on Aug. 1.

Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff

Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff

A glimpse of what to expect during Tuesday's pre-market.

EY's Greene Sees More Med Tech, CRO Deals Ahead

EY's Greene Sees More Med Tech, CRO Deals Ahead

Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.

United Therapeutics, DOJ in Possible Settlement Over Drug Contributions

United Therapeutics, DOJ in Possible Settlement Over Drug Contributions

The Justice Department is investigating the company's charitable contributions for kickbacks and false claims.

Johnson & Johnson Becomes #16 Most Shorted Dow Stock, Replacing Exxon Mobil

The most recent short interest data has been released for the 07/14/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Senate Votes to Approve Motion to Proceed on Health Care

Senate Votes to Approve Motion to Proceed on Health Care

Majority Leader Mitch McConnell needed 50 out of the 52 Senate Republicans to support him.

Report: More Than 15,000 Adverse Events Linked To Xarelto In 2016

Report: More Than 15,000 Adverse Events Linked To Xarelto In 2016

Beasley Allen: findings are "disheartening, but unfortunately not all that surprising"

Senate Poised to Hold Procedural Vote on Health Care

Senate Poised to Hold Procedural Vote on Health Care

Majority Leader Mitch McConnell needs 50 out of the 52 Senate Republicans to support him.

Chipotle Is Being Abandoned Because of Falling Rats and New Health Scare, Data Reveals

Chipotle Is Being Abandoned Because of Falling Rats and New Health Scare, Data Reveals

Not pretty for the burrito joint.

Chipotle Is Doomed Unless It Takes This One Dramatic Measure

Chipotle Is Doomed Unless It Takes This One Dramatic Measure

A total rebrand is needed.

If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog

If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog

Stock prices are either unfairly dragged down by competitors' earnings news or by Amazon's spread into more businesses, Cramer said.

Stocks Are Guilty by Association: Cramer's 'Mad Money' Recap (Thursday 7/20/17)

Stocks Are Guilty by Association: Cramer's 'Mad Money' Recap (Thursday 7/20/17)

Jim Cramer says these market rotations are crushing good stocks that don't deserve it.

Cramer: Rotations Hit Companies That Don't Deserve It

Cramer: Rotations Hit Companies That Don't Deserve It

Case in point: Home Depot and Lowe's.